Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS, with the Botnar Research Institute and Kennedy Institute of Rheumatology, has been designated a EULAR Centre of Excellence in Rheumatology 2015-2020, in recognition of our continued high-quality research publications in rheumatology.

EULAR, the European League Against Rheumatism, represents patients, health professionals and scientific societies of rheumatology of all European nations. It aims to reduce the burden of rheumatic diseases on the individual and society and to improve the treatment, prevention and rehabilitation of musculoskeletal diseases.

Its Centres of Excellence are top rheumatology research units in Europe aiming to develop a group of first-class research centres for active researchers and enable exchange of fellows and research projects.

NDORMS is one of the largest and most dynamic multidisciplinary academic rheumatology research centres in the world, with over 50 dedicated researchers focusing on rheumatic conditions.

We have one of the largest and broadest groupings of translational rheumatology research in the world; covering inflammatory, degenerative and congenital diseases of the musculoskeletal system. Scientific approaches include direct patient-focused research, epidemiology, and basic mechanistic research in immunology, genetics, bone, matrix and cartilage biology.

Professor Paul Bowness, who led on the department's application, assisted by Professor Richard Williams from the Kennedy Institute said: "We are delighted with this award and the recognition it brings to NDORMS for its research into diverse rheumatic conditions and important rheumatology research is for the lives of millions of people around the world. This supports our mission to develop and deliver excellent clinical and basic research and foster collaborations with other Centres of Excellence."

Similar stories

Study finds marked differences in the use of ankle replacements across six countries

A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.

NDORMS wins government funding to develop AI for bone health

A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.

COVID-19 vaccine safety monitoring should account for age, gender, and database differences

The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.

Professor Keith Willett recognised in Queen’s Birthday Honours

Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.

Professor Dani Prieto-Alhambra elected to ISPE Board of Directors

Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.

New research from the Kennedy Institute of Rheumatology identifies a role for CD200 in limiting atherosclerosis

A new study published in Circulation Research shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.